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Summary
Introduction:  Pleomorphic  adenoma  is  the  most  common  benign  tumour  of  the  salivary  glands.
The major  salivary  glands  are  most  commonly  involved,  or  more  rarely  accessory  salivary  glands,
especially  the  oral  cavity.  Other  locations,  such  as  the  nasal  cavity,  paranasal  sinuses  or  upper
aerodigestive  tract,  are  exceptional.
Case  report:  A  26-year-old  female  presented  with  right-sided  nasal  obstruction.  Radiology
found a  lesion  involving  the  anterior  third  of  the  nasal  septum.  The  patient  underwent  com-
plete surgical  resection  of  the  tumour  via  an  endonasal  approach.  Histological  examination
found a  mixed  cellular  component  (epithelial  and  myoepithelial)  and  mesenchymatous  tissue
with chondromyxoid  stroma,  enabling  diagnosis  of  a  typical  pleomorphic  adenoma.
Discussion/Conclusion:  Pleomorphic  adenoma  is  exceptional  in  the  nasal  cavity,  with  only  a
few cases  reported  in  the  literature.  Although  benign,  the  risk  of  local  recurrence,  malignant
transformation  and  metastasis  requires  close  long-term  follow-up.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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Pleomorphic  adenoma  (PA)  is  the  most  frequent  benign
tumour  of  the  salivary  glands.  Sixty-ﬁve  percent  of  cases
involve  the  major  salivary  glands  (MSG),  mainly  the  parotid,
and  35%  the  accessory  salivary  glands  (ASG),  mainly  the
oral  cavity  and  especially  the  palate  [1].  The  nasal  cavities,
sinuses  and  upper  aerodigestive  tract  are  only  exceptionally
involved.PA  is  a  mixed  (two-component)  tumour:  a  cellular
component  comprising  epithelial  and  myoepithelial  cells,
and  mesenchymatous  stroma  (myxoid,  hyaline,  chondroid
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http://dx.doi.org/10.1016/j.anorl.2013.03.007nd  osteoid).  Cross-sectionally,  the  aspect  is  of  a  well-
ircumscribed,  round  or  lobular  nodular  tumour  surrounded
y  a  ﬁbrous  capsule  of  varying  thickness,  of  a ﬁrm  consis-
ency  or  in  some  cases,  soft  and  myxoid  (gelatinous),  and  of
omogeneous  whitish  hue.
We  present  a  rare  case  of  PA  of  the  nasal  septum.
ase report
 26-year-old  woman  presented  in  January  2012  with  unilat-
ral  right-sided  nasal  obstruction  of  six  months’  evolution.
Rhinoscopy  found  a  mass  of  chondroid  consistency
ntirely  ﬁlling  the  right  nasal  cavity,  pedunculated  for  about
 cm  at  the  septum.
served.
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Figure  1  MRI  ﬁnds  a  circumscribed  tumor  in  the  nasal  septum,
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Figure  2  Pleomorphic  adenoma  with  mesenchymatous  com-
ponent:  chondroid  (right),  myxoid  (below)  and  epithelial
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bhowing  in  high-intensity  signal  on  T2-weighted  sequences.
MRI  found  a  well-circumscribed  polypoid  formation
nvolving  the  anterior  part  of  the  nasal  septum,  showing
n  low-intensity  signal  on  T1  and  high-intensity  signal  on
2-weighted  sequences  (Fig.  1),  heterogeneous,  with  gen-
ralized  enhancement  on  gadolinium  injection.
The  tumour  was  completely  resected,  including  a  piece  of
artilage,  with  associated  septoplasty  through  an  endonasal
pproach.  Postoperative  course  was  simple.
Pathologic  examination  found  a  well-circumscribed,
omogeneous,  ﬁrm  2.5  ×  1.2  ×  1  cm  grayish  white  tumour.
Histologic  examination  revealed  two  components:
pithelial  and  mesenchymatous.  The  former  comprised
f  basaloid  epithelial  and  spindle-shaped  myoepithelial
ells  in  trabeculae,  tubules  and  cribriform  structures;  the
atter  formed  large  chondroid  lobules  with  spaces  occupied
y  regular  chondrocytes  and  loose  myxoid  zones.  The
wo  components  were  of  varying  proportion  depending
n  the  area  (pleomorphic  aspect):  in  some  places,  the
ellular  component  predominated,  without  mitosis,  atypia
r  necrotic  sites.  The  tumour  was  well-circumscribed  by
 regular,  non-invaded  ﬁbrous  capsule,  without  perineural
nvasion  (Fig.  2).
Histologic  analysis  thus  diagnosed  typical  PA.
Simple  surveillance  was  decided  on,  facilitated  by  the
nterior  location  of  the  tumour.  Over  10  months’  follow-up,
here  were  no  signs  of  local  recurrence.
iscussionleomorphic  adenoma  of  the  nasal  cavities  is  rare,  although
wo  large  series  have  been  reported:  by  Compagno  and
ong,  with  40  cases  [2],  and  by  Suzuki  et  al.,  with  41  cases
r
c
icenter)  zones  forming  tubules  and  trabeculae  of  cubic,  basal
r myoepithelial  cells  (HES  staining).
3];  incidence  was  predominantly  female  and  in  the  30—50
ear  age  range  [2].
PA  grows  silently,  over  several  years,  in  the  MSGs,  but  is
ften  found  early  in  the  ASGs.  The  most  common  clinical
ymptoms  are  unilateral  nasal  obstruction  (71%  of  cases),
pistaxis  (56%)  and  external  deviation  of  the  nasal  pyramid
4].
The  main  risks  are  local  recurrence  [5],  malignant
ransformation  [6]  and  metastasis.  Recurrence  rates,  after
urgical  resection,  range  from  0  to  8%,  with  multiple  recur-
ence  increasing  the  risk  of  cancerization  [7].  The  risk  of
alignant  transformation  is  6%  [1]  and  is  estimated  at  1.5%
ithin  5  years  in  the  absence  of  resection  [5].
For  nasal  PA,  Compagno  and  Wong  reported  three  cases  of
ocal  recurrence  among  40  patients  (7.5%)  at  3  years’  follow-
p  [2].
Risk  factors  for  recurrence  are  predominantly  myxoid
troma,  and  an  irregular  or  invaded  capsule  and  multinodu-
arity.
Many  histological  types  of  carcinoma  are  observed:  usu-
lly  undifferentiated  carcinoma  or  adenocarcinoma,  or  less
requently  squamous-cell  carcinoma,  cystic  adenoid  carci-
oma  or  mucoepidermoid  carcinoma.
Carcinoma  included  in  an  adenoma,  said  to  be  ‘‘non-
nvasive  or  enclosed’’  or  ‘‘minimally  invasive’’  (<  1.5  mm),
s  of  very  favourable  prognosis.  When,  in  contrast,  the  car-
inoma  greatly  exceeds  the  adenoma  (>  1.5  mm),  becoming
‘invasive’’,  prognosis  is  unfavourable,  with  30%  5-year  sur-
ival  [6,8].
Treatment  in  ‘‘carcinoma  on  pleomorphic  adenoma’’  is
bviously  not  the  same  as  in  ‘‘simple’’  pleomorphic  ade-
oma,  and  the  two  have  to  be  distinguished  if  prognosis
s  to  be  assessed,  especially  as  clinical  presentation  may
e  similar.  Histology  is  the  gold  standard  for  differentiating
etween  them  and  thereby  guiding  treatment.
The  mechanisms  of  malignant  transformation,  however,
emain  poorly  understood,  and  there  is  at  present  no
onsensus  as  to  predictive  histological  criteria,  although
mmunohistochemistry  is  beginning  to  shed  some  light.
Pleomorphic  adenoma  of  the  nasal  septum  
Expression  of  the  immunohistochemical  marker  MUC1
may  be  predictive  of  recurrence  of  salivary  gland
PA  [9].
Röijer  et  al.  suggested  that  ampliﬁcation  and  overex-
pression  of  HMGIC  and  possibly  MDM2  may  be  genetic  factors
for  malignant  transformation  of  PA  [10].
Conclusion
Pleomorphic  adenoma  is  not  anodyne:  it  can  affect  loca-
tions  other  than  the  salivary  glands  and  has  a  potential
for  malignant  transformation  that  should  not  be  underes-
timated.  Prolonged  follow-up  is  therefore  mandatory.
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